Patient experience and quality of urologic cancer surgery in US hospitals

BACKGROUND Care interactions as perceived by patients and families are increasingly viewed as both an indicator and lever for high‐value care. To promote patient‐centeredness and motivate quality improvement, payers have begun tying reimbursement with related measures of patient experience. Accordingly, the authors sought to determine whether such data correlate with outcomes among patients undergoing surgery for genitourinary cancer. METHODS The authors used the Nationwide Inpatient Sample and Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) data from 2009 through 2011. They identified hospital admissions for cancer‐directed prostatectomy, nephrectomy, and cystectomy, and measured mortality, hospitalization length, discharge disposition, and complications. Mixed effects models were used to compare the likelihood of selected outcomes between the top and bottom tercile hospitals adjusting for patient and hospital characteristics. RESULTS Among a sample of 46,988 encounters, the authors found small differences in patient age, race, income, comorbidity, cancer type, receipt of minimally invasive surgery, and procedure acuity according to HCAHPS tercile ( P <.001). Hospital characteristics also varied with respect to ownership, teaching status, size, and location ( P <.001). Compared with patients treated in low‐performing hospitals, patients treated in high‐performing hospitals less often faced prolonged hospitalization (odds ratio, 0.77; 95% confidence interval, 0.64‐0.92) or nursing‐sensitive complications (odds ratio, 0.85; 95% confidence interval, 0.72‐0.99). No difference was found with regard to inpatient mortality, other complications, and discharge disposition ( P >.05). CONCLUSIONS Using Nationwide Inpatient Sample and HCAHPS data, the authors found a limited association between patient experience and surgical outcomes. For urologic cancer surgery, patient experience may be optimally viewed as an independent quality domain rather than a mechanism with which to improve surgical outcomes. Cancer 2016;122:2571–8 . © 2016 American Cancer Society .